July 20, 2018 – The last thing that a cancer patient wants to do after receiving a chemotherapy treatment is to get in a car for a long drive home. But that’s exactly what some Nebraska patients would need to do if Johnson County Hospital weren’t able to provide that care locally. “The nearest tertiary hospital is approximately 45 miles to over 100 miles away,” said Olivia … [Read more...]
Faces of 340B: A Story About Family
June 11, 2018 – For Sandy Clark, the 340B program is personal. She was inspired to become a 340B coordinator due to the experience of one special patient in particular – her own son. Sandy’s son was diagnosed with Hodgkin’s lymphoma in 2005, just a month before graduating from high school. At the time, Meadville Medical Center in northwestern Pennsylvania did not have the … [Read more...]
Faces of 340B: “We Stand in that Gap”
May 24, 2018 – For Chuck Beams, it was one patient in particular who made him realize just how crucial the 340B program is to uninsured and underinsured patients with serious medical conditions. The patient from Auburn, Ala., required tens of thousands of dollars in infusions and other costly care for his cancer and had no idea how he was going to obtain the treatments until he … [Read more...]
Does 340B Really Drive Up the Cost Of Cancer Care?
Feb. 8, 2018— Academic experts continue to question claims that the 340B drug discount program is the cause of consolidations of private physician practices and community-based hospitals. They argue the trend toward consolidation is much more complex and due to a series of factors, including changes in reimbursement policies. In the Feb. 8 issue of Forbes magazine, Duke … [Read more...]
Health Policy Experts Question Findings in Controversial NEJM Study
February 2, 2018—A team of independent health policy experts have questioned the major findings in a recent New England Journal of Medicine (NEJM) study critical of the 340B drug pricing program. In its Jan. 24 issue, the journal published a study authored by Sunita Desai, Ph.D., and J. Michael McWilliams, M.D., Ph.D., that raised questions about whether 340B hospitals are … [Read more...]
340B Hospital Leaders Urge Congress to Block Devastating Medicare Cuts
November 29, 2017—Hospital leaders from 23 states are on Capitol Hill today to urge passage of a bipartisan bill to stop deep reductions in Medicare Part B drug payments to hospitals that participate in the 340B drug discount program. Across the country, meanwhile, 340B hospitals are contacting their lawmakers via email and social media to convey their deep concerns about the … [Read more...]
Co-Founder of GOP Doctor’s Caucus Urges CMS To Withdraw Reimbursement Cut
October 11, 2017—The Centers for Medicare & Medicaid Services should “stand down and rescind its deleterious proposal” to slash what Medicare pays 340B hospitals for many of the most expensive medicines in use today, a co-founder of the U.S. House GOP Doctors Caucus says. In a recent commentary in the Capitol Hill newspaper The Hill, former Rep. Phil Gingrey (R-Ga.) … [Read more...]